Innospec (IOSP) Receiving Somewhat Positive News Coverage, Analysis Finds
Media stories about Innospec (NASDAQ:IOSP) have been trending somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innospec earned a news impact score of 0.09 on Accern’s scale. Accern also assigned news coverage about the specialty chemicals company an impact score of 46.3262320661202 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Innospec (IOSP) traded up 0.97% during mid-day trading on Friday, hitting $57.00. 145,152 shares of the stock were exchanged. The firm has a market capitalization of $1.38 billion, a price-to-earnings ratio of 18.15 and a beta of 1.18. Innospec has a 52 week low of $54.10 and a 52 week high of $74.75. The company’s 50-day moving average price is $57.67 and its 200 day moving average price is $62.47.
Innospec (NASDAQ:IOSP) last posted its earnings results on Tuesday, August 8th. The specialty chemicals company reported $1.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $0.08. Innospec had a net margin of 7.22% and a return on equity of 14.77%. The firm had revenue of $326.30 million for the quarter. Equities research analysts expect that Innospec will post $4.28 EPS for the current year.
Several analysts have issued reports on the stock. Zacks Investment Research lowered shares of Innospec from a “buy” rating to a “hold” rating and set a $63.00 price target for the company. in a research report on Tuesday, September 12th. BidaskClub lowered shares of Innospec from a “hold” rating to a “sell” rating in a research report on Thursday, June 22nd. ValuEngine lowered shares of Innospec from a “buy” rating to a “hold” rating in a research report on Monday, August 7th. Finally, Monness Crespi & Hardt upgraded shares of Innospec from a “neutral” rating to a “buy” rating and set a $65.00 price target for the company in a research report on Tuesday, August 22nd.
COPYRIGHT VIOLATION NOTICE: “Innospec (IOSP) Receiving Somewhat Positive News Coverage, Analysis Finds” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/09/17/innospec-iosp-receiving-somewhat-positive-news-coverage-analysis-finds.html.
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
Receive News & Stock Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related stocks with our FREE daily email newsletter.